This site is intended for heath plan professionals in Canada.

This site is intended for health plan professionals in Canada.

U.S. professionals should visit ManagedCareCGM.com

Continuous Glucose Monitoring

Continuous Glucose Monitoring - CGM

Insights & Education for Health Benefit Plan Professionals in Canada

Using CGM to Aid in Virtual Care and Improve Diabetes Management

Unveiling the Latest Evidence:
CGM’s Evolving Impact on Diabetes Care

CGM Improves Glycemic Control and
Reduces CVD Risk in Non-Insulin-Treated T2D 

Next-Generation Dexcom G7 CGM
System Approved by Health Canada

ADA 2023 Highlights:
The Clinical and Economic Value of CGM


Watch Now

Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (rt-CGM) vs. Intermittent-Scanning Continuous Glucose Monitoring (is-CGM) in Patients with Type 2 Diabetes on Multiple Daily Injections of Insulin (T2D MDI) in Canada

Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (rt-CGM) vs. Intermittent-Scanning Continuous Glucose Monitoring (is-CGM) in Patients with Type 2 Diabetes on Multiple Daily Injections of Insulin (T2D MDI) in Canada – Diabetes– June 20, 2023

Read More

New Diabetes Technology & Therapeutics Supplement Highlights the Latest CGM Evidence and Insights

New Supplement Highlights the Latest CGM Evidence and Insights – Diabetes Technology and Therapeutics – June 2023

Read More

LOIS-P Looks at Hypoglycemia Incidence with Sensor-Augmented Pump in Pregnancy

LOIS-P Looks at Hypoglycemia Incidence with Sensor-Augmented Pump in Pregnancy – Diabetes Technology and Therapeutics 

Read More

LOIS-P Study Examines Insulin Use and Glycemic Control in Pregnancy with CGM

LOIS-P Study Examines Insulin Use and Glycemic Control in Pregnancy with CGM – Diabetes Technology and Therapeutics – November, 2021

Read More

At Home Use of Closed Loop Insulin System in Pregnancy Determined to be Feasible

At Home Use of Closed Loop Insulin System in Pregnancy Determined to be Feasible – Diabetes Care – May 17, 2023

Read More